Methyl iodide → HCID 58484695, compound
Reaction equation
[C:1]([C:3]1[CH:4]=[C:5]([N:27]2[C@H:31]([CH2:32][OH:33])[CH2:30][O:29][C:28]2=[O:34])[CH:6]=[CH:7][C:8]=1[C:9]([N:11]1[CH2:16][CH2:15][N:14]([C:17]2[C:22]([CH3:23])=[CH:21][C:20]([CH:24]3[CH2:26][CH2:25]3)=[CH:19][N:18]=2)[CH2:13][CH2:12]1)=[O:10])#[N:2].[CH3:35]I>>[C:1]([C:3]1[CH:4]=[C:5]([N:27]2[C@H:31]([CH2:32][O:33][CH3:35])[CH2:30][O:29][C:28]2=[O:34])[CH:6]=[CH:7][C:8]=1[C:9]([N:11]1[CH2:12][CH2:13][N:14]([C:17]2[C:22]([CH3:23])=[CH:21][C:20]([CH:24]3[CH2:26][CH2:25]3)=[CH:19][N:18]=2)[CH2:15][CH2:16]1)=[O:10])#[N:2]Participants
3
Procedure
By reaction and treatment in the same manner as in Preparation Example 93 and using (R)-3-{3-cyano-4-[4-(5-cyclopropyl-3-methylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-hydroxymethyloxazolidin-2-one (600 mg) described in Example 357 and methyl iodide (221 mg), the title compound (339 mg) was obtained.
Workup
- customBy reaction and treatment in the same manner
- customas in Preparation Example 93
Sources & evidence
- ORD record
- ord-d25319a06c09408080c8609275832835
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…